#VisualAbstract: Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy
Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to...
Read MoreApr 1, 2022
Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to...
Read MoreMar 30, 2022
Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema...
Read MoreMar 27, 2022
For children with non-severe tuberculosis, 4 months of antituberculosis treatments was...
Read MoreMar 23, 2022
Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable...
Read MoreMar 23, 2022
Click to read this study in JAMA Network Open.
Read MoreMar 23, 2022
Click to read this study in the Journal of the American Academy of Dermatology.
Read MoreMar 15, 2022
Click to read this study in JAMA Dermatology.
Read MoreMar 11, 2022
Compared to placebo, children who received peanut oral immunotherapy experienced significantly...
Read MoreMar 9, 2022
Rates of sustained return of spontaneous circulation after non-traumatic out-of-hospital cardiac...
Read MoreMar 9, 2022
Click to read this study in JAMA Network Open.
Read MoreMar 9, 2022
Click to read this study in JAMA Network Open.
Read MoreMar 4, 2022
1. All-cause mortality at 28 days was significantly higher in the usual care group compared to the...
Read MoreMar 3, 2022
Click to read this study in JAMA Oncology.
Read MoreMar 2, 2022
Click to read this study in JAMA Dermatology.
Read More